These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22080833)

  • 21. Unusual familial presentation of epsilon-sarcoglycan gene mutation with falls and writer's cramp.
    Koukouni V; Valente EM; Cordivari C; Bhatia KP; Quinn NP
    Mov Disord; 2008 Oct; 23(13):1913-5. PubMed ID: 18702114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice.
    Yokoi F; Dang MT; Li J; Li Y
    J Biochem; 2006 Jul; 140(1):141-6. PubMed ID: 16815860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neurophysiological features of myoclonus-dystonia and differentiation from other dystonias.
    Popa T; Milani P; Richard A; Hubsch C; Brochard V; Tranchant C; Sadnicka A; Rothwell J; Vidailhet M; Meunier S; Roze E
    JAMA Neurol; 2014 May; 71(5):612-9. PubMed ID: 24638021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ε-Sarcoglycan: Unraveling the Myoclonus-Dystonia Gene.
    Cazurro-Gutiérrez A; Marcé-Grau A; Correa-Vela M; Salazar A; Vanegas MI; Macaya A; Bayés À; Pérez-Dueñas B
    Mol Neurobiol; 2021 Aug; 58(8):3938-3952. PubMed ID: 33886091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome.
    Zimprich A; Grabowski M; Asmus F; Naumann M; Berg D; Bertram M; Scheidtmann K; Kern P; Winkelmann J; Müller-Myhsok B; Riedel L; Bauer M; Müller T; Castro M; Meitinger T; Strom TM; Gasser T
    Nat Genet; 2001 Sep; 29(1):66-9. PubMed ID: 11528394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype.
    Peall KJ; Kurian MA; Wardle M; Waite AJ; Hedderly T; Lin JP; Smith M; Whone A; Pall H; White C; Lux A; Jardine PE; Lynch B; Kirov G; O'Riordan S; Samuel M; Lynch T; King MD; Chinnery PF; Warner TT; Blake DJ; Owen MJ; Morris HR
    J Neurol; 2014 Dec; 261(12):2296-304. PubMed ID: 25209853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel conserved mutation in SGCE gene in 3 unrelated patients with classical phenotype myoclonus-dystonia syndrome.
    Szubiga M; Rudzińska M; Bik-Multanowski M; Pietrzyk JJ; Szczudlik A
    Neurol Res; 2013 Jul; 35(6):659-62. PubMed ID: 23561547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel SGCE variant is associated with myoclonus-dystonia with phenotypic variability.
    Delgado-Alvarado M; Matilla-Dueñas A; Altadill-Bermejo A; Setién S; Misiego-Peral M; Sánchez-de la Torre JR; Corral-Juan M; Riancho J
    Neurol Sci; 2020 Dec; 41(12):3779-3781. PubMed ID: 32955639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene.
    Asmus F; Salih F; Hjermind LE; Ostergaard K; Munz M; Kühn AA; Dupont E; Kupsch A; Gasser T
    Ann Neurol; 2005 Nov; 58(5):792-7. PubMed ID: 16240355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the epsilon-sarcoglycan (SGCE) gene phenotypic signature in myoclonus-dystonia: a reappraisal of genetic testing criteria.
    Carecchio M; Magliozzi M; Copetti M; Ferraris A; Bernardini L; Bonetti M; Defazio G; Edwards MJ; Torrente I; Pellegrini F; Comi C; Bhatia KP; Valente EM
    Mov Disord; 2013 Jun; 28(6):787-94. PubMed ID: 23677909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delineating the motor phenotype of SGCE-myoclonus dystonia syndrome.
    Vanegas MI; Marcé-Grau A; Martí-Sánchez L; Mellid S; Baide-Mairena H; Correa-Vela M; Cazurro A; Rodríguez C; Toledo L; Fernández-Ramos JA; Pons R; Aguilera-Albesa S; Martí MJ; Eiris J; Iglesias G; De Fabregues O; Maqueda E; Garriz-Luis M; Madruga M; Espinós C; Macaya A; Cabrera JC; Pérez-Dueñas B
    Parkinsonism Relat Disord; 2020 Nov; 80():165-174. PubMed ID: 33022436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to ε-sarcoglycan mutations: a pilot study.
    Azoulay-Zyss J; Roze E; Welter ML; Navarro S; Yelnik J; Clot F; Bardinet E; Karachi C; Dormont D; Galanaud D; Pidoux B; Cornu P; Vidailhet M; Grabli D
    Arch Neurol; 2011 Jan; 68(1):94-8. PubMed ID: 21220679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myoclonus-dystonia due to maternal uniparental disomy.
    Guettard E; Portnoi MF; Lohmann-Hedrich K; Keren B; Rossignol S; Winkler S; El Kamel I; Leu S; Apartis E; Vidailhet M; Klein C; Roze E
    Arch Neurol; 2008 Oct; 65(10):1380-5. PubMed ID: 18852357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed Diagnoses of
    Varga MG; Nand NP; LeDoux MS
    Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():23. PubMed ID: 32775037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortical neuronal hyperexcitability and synaptic changes in SGCE mutation-positive myoclonus dystonia.
    Sperandeo A; Tamburini C; Noakes Z; de la Fuente DC; Keefe F; Petter O; Plumbly W; Clifton NE; Li M; Peall KJ
    Brain; 2023 Apr; 146(4):1523-1541. PubMed ID: 36204995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myoclonus dystonia syndrome: a novel ε-sarcoglycan gene mutation with variable clinical symptoms.
    Akbari MT; Mirfakhraie R; Zare-Karizi S; Shahidi G
    Gene; 2014 Sep; 548(2):306-7. PubMed ID: 25034659
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical differentiation of genetically proven benign hereditary chorea and myoclonus-dystonia.
    Asmus F; Devlin A; Munz M; Zimprich A; Gasser T; Chinnery PF
    Mov Disord; 2007 Oct; 22(14):2104-9. PubMed ID: 17702043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myoclonus-dystonia syndrome.
    Nardocci N
    Handb Clin Neurol; 2011; 100():563-75. PubMed ID: 21496608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twenty years on: Myoclonus-dystonia and ε-sarcoglycan - neurodevelopment, channel, and signaling dysfunction.
    Menozzi E; Balint B; Latorre A; Valente EM; Rothwell JC; Bhatia KP
    Mov Disord; 2019 Nov; 34(11):1588-1601. PubMed ID: 31449710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exclusive paternal expression and novel alternatively spliced variants of epsilon-sarcoglycan mRNA in mouse brain.
    Yokoi F; Dang MT; Mitsui S; Li Y
    FEBS Lett; 2005 Aug; 579(21):4822-8. PubMed ID: 16099459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.